Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer

Breast cancer (BC) is the most common cause of cancer-related death in women worldwide. Therapies targeting molecular pathways altered in BC had significantly enhanced treatment options for BC over the last decades, which ultimately improved the lives of millions of women worldwide. Among various mo...

Full description

Saved in:
Bibliographic Details
Published in:Cells
Main Authors: Sobhani, Navid, Fassl, Anne, Mondani, Giuseppina, Generali, Daniele, Otto, Tobias
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7912842/
https://ncbi.nlm.nih.gov/pubmed/33535617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10020293
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items